Auditory brainstem response demonstrates that reduced peripheral auditory input is associated with self-report of tinnitus
[10] These tend to subside with time
For type 2 diabetes management , NICE guideline NG28 recommends considering GLP-1 receptor agonists when: Triple therapy with metformin and two other oral medications is ineffective, not tolerated or contraindicated The patient has a body mass index (BMI) of 35 kg/m or higher (with lower thresholds for people from certain ethnic backgrounds), or lower BMI with specific clinical circumstances where weight loss would benefit other obesity-related comorbidities Insulin would have significant occupational implications GLP-1 therapy should only be continued beyond six months if there has been a beneficial metabolic response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0 percentage point) and weight loss of at least 3% of initial body weight
The safest editorial rule is direct: describe what researchers examined, cite the source, and avoid expanding the finding beyond the model
2 As a group, the selected drugs are indicated for multiple conditions including Type 2 diabetes, cardiovascular disease, and obesity although the selected products do not share identical product indications
Informed patients trust you more over time